These data suggest that reduced levels of Kv1.5 protein in biopsies when compared to the levels found in adjacent healthy tissues may be a good candidate biomarker for both glioma detection and outcome prediction (Preußat et al., 2003). Here, KCNA5 is linked to glioma.